CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 71 filers reported holding CYTOSORBENTS CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $661,000 | -69.7% | 131,472 | -60.2% | 0.00% | -50.0% |
| Q2 2019 | $2,182,000 | -13.4% | 330,086 | -0.8% | 0.00% | 0.0% |
| Q1 2019 | $2,520,000 | -7.4% | 332,870 | -1.1% | 0.00% | -33.3% |
| Q4 2018 | $2,720,000 | -39.8% | 336,632 | -3.9% | 0.00% | -25.0% |
| Q3 2018 | $4,517,000 | +53.8% | 350,178 | +35.9% | 0.00% | +33.3% |
| Q2 2018 | $2,937,000 | – | 257,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 249,430 | $2,015,000 | 1.24% |
| Manatuck Hill Partners, LLC | 194,100 | $1,568,000 | 0.81% |
| Skylands Capital, LLC | 495,850 | $4,006,000 | 0.66% |
| EAM Global Investors LLC | 78,027 | $630,000 | 0.34% |
| EAM Investors, LLC | 107,531 | $869,000 | 0.24% |
| Granahan Investment Management | 278,170 | $2,248,000 | 0.16% |
| Wealthcare Advisory Partners LLC | 62,079 | $502,000 | 0.10% |
| Avenir Corp | 76,390 | $617,000 | 0.08% |
| Crow Point Partners, LLC | 48,576 | $380,000 | 0.07% |
| Kalos Management, Inc. | 14,700 | $120,000 | 0.06% |